Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial.
PARISH S. et al, (2023), European Heart Journal
SAMMONS E. et al, (2023), Ophthalmology
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
Wu R. et al, (2023), British Journal of General Practice
Evaluation of interventions to prevent vasovagal reactions among whole blood donors: rationale and design of a large cluster randomised trial.
McMahon A. et al, (2023), Trials, 24
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
SAMMONS E. et al, (2023), Contemporary Clinical Trials Communications
Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
MAFHAM M. et al, (2023), Heart
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
PARISH S. et al, (2023), Trials
Huo X. et al, (2023), Current Developments in Nutrition, 7
Heise V. et al, (2023)
Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK
Zhou J. et al, (2022), PharmacoEconomics
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet (London, England), 400, 832 - 845
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
BAIGENT C. et al, (2022), The Lancet
Keng MJ. et al, (2022), Diabetes, Obesity and Metabolism
Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial.
Song J. et al, (2022), Trials, 23
Parish S. et al, (2022), Eur Heart J
HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424
Decrements in health-related quality of life associated with adverse events in people with diabetes.
Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538
Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16
Impact of adverse events on hospital costs and health-related quality of life in people with diabetes
Keng MJ. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials
Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186